Search Clinical Trials
597,593 trials
ID
Status
Phase
Title
Sponsor
NCT07754253
Effectiveness of Epigallocatechin-3-Gallate (Green Tea Extract) as Adjunctive Locally Delivered Nanotherapeutic in the Treatment of Stage II PeriodontitisMansoura UniversityRecruitingPhase 1
NCT07754253Recruiting
Phase 1
Effectiveness of Epigallocatechin-3-Gallate (Green Tea Extract) as Adjunctive Lo...Mansoura University
NCT07755878
Blended Cardiac Rehabilitation Training for Cardiology ResidentsSecond Affiliated Hospital, Zhejiang University, School of MedicineActive Not RecruitingNot Applicable
NCT07755878Active Not Recruiting
Not Applicable
Blended Cardiac Rehabilitation Training for Cardiology ResidentsSecond Affiliated Hospita...
NCT07756554
Clinical Assessment and Treatment in the Nursing Home as an Alternative to Hospital AdmissionAmager HospitalRecruitingNot Applicable
NCT07756554Recruiting
Not Applicable
Clinical Assessment and Treatment in the Nursing Home as an Alternative to Hospi...Amager Hospital
NCT07755176
Patient-reported Outcomes Following Percutaneous Ablation of Desmoid TumorsMayo ClinicEnrolling By Invitation
NCT07755176Enrolling By Invitation
—
Patient-reported Outcomes Following Percutaneous Ablation of Desmoid TumorsMayo Clinic
NCT07755254
Frailty and Dependency in Older Adults Undergoing Cardiac SurgeryAydin Adnan Menderes UniversityActive Not Recruiting
NCT07755254Active Not Recruiting
—
Frailty and Dependency in Older Adults Undergoing Cardiac SurgeryAydin Adnan Menderes Univ...
NCT07755852
Transcranial Temporal Interference Stimulation (tTIS) for Chronic InsomniaRuijin HospitalNot Yet RecruitingNot Applicable
NCT07755852Not Yet Recruiting
Not Applicable
Transcranial Temporal Interference Stimulation (tTIS) for Chronic InsomniaRuijin Hospital
NCT07754968
Use of Bifidobacterium Bifidum in Formula-Fed Infants With Colic, With or Without Atopic DermatitisUniversity of Roma La SapienzaRecruitingNot Applicable
NCT07754968Recruiting
Not Applicable
Use of Bifidobacterium Bifidum in Formula-Fed Infants With Colic, With or Withou...University of Roma La Sap...
NCT07756450
Impact of Obesity on Textbook Outcome Achievement in Minimally Invasive Colorectal Cancer SurgeryBakirkoy Dr. Sadi Konuk Research and Training HospitalCompleted
NCT07756450Completed
—
Impact of Obesity on Textbook Outcome Achievement in Minimally Invasive Colorect...Bakirkoy Dr. Sadi Konuk R...
NCT07754604
Effects of Mental Fatigue Duration on Cortical Activity and Jump PerformanceInonu UniversityCompletedNot Applicable
NCT07754604Completed
Not Applicable
Effects of Mental Fatigue Duration on Cortical Activity and Jump PerformanceInonu University
NCT07754578
DOSE-UP: Dose Optimization for Smoking and E-Cigarette Use PharmacotherapyMedical University of South CarolinaNot Yet RecruitingPhase 2
NCT07754578Not Yet Recruiting
Phase 2
DOSE-UP: Dose Optimization for Smoking and E-Cigarette Use PharmacotherapyMedical University of Sou...
NCT07755631
The BASIC-S Feasibility Study for Vascular Risk ReductionAcademic Medical Organization of Southwestern OntarioNot Yet RecruitingNot Applicable
NCT07755631Not Yet Recruiting
Not Applicable
The BASIC-S Feasibility Study for Vascular Risk ReductionAcademic Medical Organiza...
NCT07755761
Innovative Tube Trabeculectomy for Advanced and Refractory Glaucoma: A Randomized Controlled TrialBenha UniversityRecruitingNot Applicable
NCT07755761Recruiting
Not Applicable
Innovative Tube Trabeculectomy for Advanced and Refractory Glaucoma: A Randomize...Benha University
NCT07754695
Measuring Normal Esophageal Flexibility in Children Using EndoFLIPIndiana UniversityNot Yet Recruiting
NCT07754695Not Yet Recruiting
—
Measuring Normal Esophageal Flexibility in Children Using EndoFLIPIndiana University
NCT07756281
First in Human Study of SNV1521 With a RAS Inhibitor for People With Advanced Pancreatic CancerRevolution Medicines, Inc.Not Yet RecruitingPhase 1
NCT07756281Not Yet Recruiting
Phase 1
First in Human Study of SNV1521 With a RAS Inhibitor for People With Advanced Pa...Revolution Medicines, Inc...
NCT07756008
Bladder-Sparing Treatment With Disitamab Vedotin and Toripalimab With or Without Pelvic Lymph Node Dissection in Bladder CancerSun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot Yet RecruitingPhase 2
NCT07756008Not Yet Recruiting
Phase 2
Bladder-Sparing Treatment With Disitamab Vedotin and Toripalimab With or Without...Sun Yat-Sen Memorial Hosp...
NCT07755917
Preoperative Home-based Multimodal Prehabilitation Based on 5G + Artificial Intelligence Mobile HealthDongying People's HospitalNot Yet RecruitingNot Applicable
NCT07755917Not Yet Recruiting
Not Applicable
Preoperative Home-based Multimodal Prehabilitation Based on 5G + Artificial Inte...Dongying People's Hospita...
NCT07754708
The Effect of Carpal Tunnel Syndrome Phenotyping on Response to TreatmentKutahya Health Sciences UniversityNot Yet RecruitingNot Applicable
NCT07754708Not Yet Recruiting
Not Applicable
The Effect of Carpal Tunnel Syndrome Phenotyping on Response to TreatmentKutahya Health Sciences U...
NCT07755670
Exploration of Brain Functional Networks in Patients With Hidradenitis Suppurativa Using fMRISecond Xiangya Hospital of Central South UniversityRecruiting
NCT07755670Recruiting
—
Exploration of Brain Functional Networks in Patients With Hidradenitis Suppurati...Second Xiangya Hospital o...
NCT07754994
Medication Self-Management Technology for Older AdultsArizona State UniversityNot Yet RecruitingNot Applicable
NCT07754994Not Yet Recruiting
Not Applicable
Medication Self-Management Technology for Older AdultsArizona State University
NCT07753772
Dexmedetomidine-Esketamine Combination on Depression and Anxiety After Laparoscopic Ureteral ReconstructionPeking University First HospitalNot Yet RecruitingPhase 4
NCT07753772Not Yet Recruiting
Phase 4
Dexmedetomidine-Esketamine Combination on Depression and Anxiety After Laparosco...Peking University First H...
Result Breakdown
Not yet recruiting10 (50%)
Recruiting5 (25%)
Active, not recruiting2 (10%)
Completed2 (10%)
Enrolling by invitation1 (5%)
not_applicable10 (50%)
Not Specified5 (25%)
Phase 12 (10%)
Phase 22 (10%)
Phase 41 (5%)